Stage III Liver Cancer
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stage IV Liver Cancer
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stage IIIA Adult Liver Cancer AJCC v7
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stage IIIB Adult Liver Cancer AJCC v7
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stage IV Adult Liver Cancer AJCC v7
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stage III Adult Liver Cancer AJCC v7
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stage IIIC Adult Liver Cancer AJCC v7
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Transitional cell papilloma, benign
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Lung disease with systemic sclerosis
|
disease |
Skin and Connective Tissue Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Sinistrocardia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Acute hypercapnic respiratory failure
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Non-dipping
|
disease |
|
Disease or Syndrome
|
5
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pulmonary arterial hypertension associated with congenital heart disease
|
disease |
|
Disease or Syndrome
|
5
|
11
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Sickle cell-beta-thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
< 0.001 |
1 |
|
2014 |
2014 |
Non-ischemic dilated cardiomyopathy
|
disease |
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hemosiderosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
8
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Congenital dyserythropoietic anemia, type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
8
|
12
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Prostatic Adenoma
|
disease |
Male Urogenital Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Non-transfusion dependent thalassaemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Tuberculosis, Central Nervous System
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pelvic Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Non ST segment elevation acute coronary syndrome
|
disease |
|
Disease or Syndrome
|
12
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Acute chest pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chronic systolic heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Gigantism
|
disease |
Musculoskeletal Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
16
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |